- Report
- March 2026
- 209 Pages
Germany
From €4480EUR$4,850USD£3,747GBP
- Report
- March 2026
- 175 Pages
China
From €4480EUR$4,850USD£3,747GBP
- Report
- March 2026
- 150 Pages
Canada
From €4480EUR$4,850USD£3,747GBP
- Report
- March 2026
- 243 Pages
India
From €4480EUR$4,850USD£3,747GBP
- Report
- December 2024
- 150 Pages
Global
From €4480EUR$4,850USD£3,747GBP
- Report
- March 2024
- 150 Pages
Global
From €4480EUR$4,850USD£3,747GBP
- Report
- January 2024
- 150 Pages
Global
From €4480EUR$4,850USD£3,747GBP
- Report
- October 2025
- 88 Pages
Middle East
From €4156EUR$4,500USD£3,477GBP
- Report
- October 2025
- 94 Pages
Philippines
From €4156EUR$4,500USD£3,477GBP
- Report
- October 2024
- 88 Pages
Global
From €3500EUR$4,059USD£3,030GBP
- Report
- January 2025
- 132 Pages
Global
From €877EUR$950USD£734GBP
- Book
- October 2012
- 1570 Pages

Dengue is a mosquito-borne viral infection that is found in tropical and subtropical regions around the world. Infectious disease testing for dengue is used to diagnose the presence of the virus in a patient. Diagnostic tests for dengue include serological tests, such as enzyme-linked immunosorbent assays (ELISA) and rapid diagnostic tests (RDTs). These tests detect the presence of antibodies in the patient's blood, which indicate a current or past infection. Molecular tests, such as polymerase chain reaction (PCR) tests, are also used to detect the presence of the virus in the patient's blood.
There are a number of companies that offer dengue testing products and services. These include bioMérieux, Abbott, Bio-Rad, DiaSorin, and Hologic. Other companies, such as Alere, Becton Dickinson, and Cepheid, offer molecular testing products for dengue. Additionally, there are a number of companies that offer point-of-care testing products for dengue, such as Chembio Diagnostics and SD Biosensor. Show Less Read more